Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Fully Valued Stocks on NYSE
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on NYSE
Today’s data is for companies listed on the New York Stock Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2019 | 107.600000 | 95.8000 | USD | 5 |
| BDX | Becton, Dickinson and Co | 2019 | 264.380000 | 252.0000 | USD | 3 |
| BAX | Baxter International Inc | 2019 | 77.800000 | 62.0000 | USD | 3 |
| SQ | Square Inc | 2019 | 97.280000 | 85.1667 | USD | 6 |
| GWW | W.W. Grainger Inc | 2019 | 356.000000 | 339.3333 | USD | 3 |
| CLX | Clorox Co | 2019 | 150.430000 | 127.0000 | USD | 4 |
| RMD | ResMed Inc | 2019 | 115.170000 | 98.0008 | USD | 1 |
| VEEV | Veeva Systems Inc | 2020 | 105.200000 | 93.2500 | USD | 4 |
| IT | Gartner Inc | 2019 | 158.270000 | 148.0000 | USD | 1 |
| W | Wayfair Inc | 2019 | 143.640000 | 111.5000 | USD | 4 |
| PKI | PerkinElmer Inc | 2019 | 96.740000 | 85.3333 | USD | 3 |
| PAYC | Paycom Software Inc | 2019 | 150.800000 | 122.6000 | USD | 5 |
| FDS | FactSet Research Systems Inc | 2019 | 225.390000 | 204.6667 | USD | 3 |
| RHI | Robert Half International Inc | 2019 | 69.400000 | 52.5000 | USD | 2 |
| AYI | Acuity Brands Inc | 2019 | 155.180000 | 130.0000 | USD | 2 |
| VNE | Veoneer Inc | 2019 | 55.530000 | 41.2500 | USD | 4 |
| CLH | Clean Harbors Inc | 2019 | 70.890000 | 52.0000 | USD | 1 |
| SAM | Boston Beer Co Inc | 2019 | 288.550000 | 210.0000 | USD | 1 |
| KWR | Quaker Chemical Corp | 2019 | 202.800000 | 165.0000 | USD | 1 |
| SRG | Seritage Growth Properties | 2019 | 47.880000 | 34.0000 | USD | 1 |
| AWR | American States Water Co | 2019 | 60.070000 | 46.0000 | USD | 1 |
| DDS | Dillard’s Inc | 2020 | 77.180000 | 66.0000 | USD | 1 |
| WK | Workiva Inc | 2019 | 40.010000 | 24.0000 | USD | 1 |
| USPH | US Physical Therapy Inc | 2019 | 113.200000 | 90.0000 | USD | 1 |
| GHL | Greenhill & Co Inc | 2019 | 26.680000 | 13.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
LLY:NYS Eli Lilly
http://www.lilly.com
Eli Lilly has 40655 employees and is headquartered in United States.
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
BDX:NYS Becton
http://www.bd.com
Becton has 41933 employees and is headquartered in United States.
Becton, Dickinson and Co is a healthcare company. It manufacture and sales medical supplies, devices, laboratory equipment and diagnostic products. It operates in two segments BD Medical and BD Life Sciences.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.